BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 The Banff 97 working classification of renal allograft pathology.
41 auth. L. Racusen, K. Solez, R. Colvin, S. Bonsib, M. C. Castro, T. Cavallo, B. Croker, A. Demetris, C. Drachenberg, A. Fogo, P. Furness, L. Gaber, I. Gibson, Dennis Glotz, J. Goldberg, ... Joseph Grande, P. Halloran, H. E. Hansen, B. Hartley, P. Hayry, C. Hill, Ernesto O. Hoffman, L. Hunsicker, A. Lindblad, N. Marcussen, M. Mihatsch, T. Nadasdy, P. Nickerson, T. Olsen, J. Papadimitriou, P. Randhawa, D. Rayner, I. Roberts, S. Rose, D. Rush, L. Salinas‐Madrigal, D. Salomon, S. Sund, E. Taskinen, K. Trpkov, Y. Yamaguchi
11 1999
11
🐜
🐜 International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.
28 auth. K. Solez, R. Axelsen, H. Benediktsson, J. Burdick, A. Cohen, R. Colvin, B. Croker, D. Droz, M. Dunnill, P. Halloran, P. Häyry, J. Jennette, P. Keown, N. Marcussen, M. Mihatsch, ... K. Morozumi, B. Myers, C. Nast, S. Olsen, L. Racusen, E. Ramos, S. Rosen, D. Sachs, D. Salomon, F. Sanfilippo, R. Verani, E. von Willebrand, Y. Yamaguchi
10 1993
10
🐜
🐜 Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’)
31 auth. K. Solez, R. Colvin, L. Racusen, B. Sis, P. Halloran, P. Birk, P. Campbell, M. Cascalho, A. Collins, A. Demetris, C. Drachenberg, I. Gibson, P. Grimm, M. Haas, E. Lerut, ... H. Liapis, R. Mannon, P. B. Marcus, M. Mengel, M. Mihatsch, B. Nankivell, V. Nickeleit, J. Papadimitriou, J. Platt, P. Randhawa, I. Roberts, L. Salinas-Madriga, D. Salomon, D. Serón, M. Sheaff, J. Weening
10 2007
10
🐜
🐜 Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection
28 auth. L. Racusen, R. Colvin, K. Solez, M. Mihatsch, P. Halloran, P. Campbell, M. Cecka, J. Cosyns, A. Demetris, M. Fishbein, A. Fogo, P. Furness, I. Gibson, D. Glotz, P. Hayry, ... Lawrence Hunsickern, M. Kashgarian, R. Kerman, A. Magil, R. Montgomery, K. Morozumi, V. Nickeleit, P. Randhawa, H. Regele, D. Serón, S. Seshan, S. Sund, K. Trpkov
10 2003
10
🐜
🐜 A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
36 auth. P. Keown, P. Häyry, P. Morris, C. Stiller, C. Barker, L. Carr, D. Landsberg, I. Hardie, R. Rigby, H. Isoniemi, D. Gray, P. Belitsky, A. McDonald, T. Mathew, A. Clarkson, ... L. Barratt, B. Buchholz, R. Walker, G. Kirste, N. Muirhead, D. Tiller, G. Duggin, P. Halloran, P. Daloze, G. S. Louis, D. Russell, D. Ludwin, P. Vialtel, U. Binswanger, J. Buckels, J. Touraine, D. Hickey, G. Remuzzi, G. Locatelli, F. Lam, E. Tapper
10 1996
10
🐜
🐢 Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence
10 auth. J. Sellarés, D. Freitas, M. Mengel, J. Reeve, G. Einecke, B. Sis, ... L. Hidalgo, K. Famulski, A. Matas, P. Halloran
9 2012
9
🐢
🐜 The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials
30 auth. M. Haas, A. Loupy, C. Lefaucheur, C. Roufosse, D. Glotz, D. Serón, B. Nankivell, P. Halloran, R. Colvin, E. Akalin, N. Alachkar, S. Bagnasco, Y. Bouatou, Y. Bouatou, J. Becker, ... L. Cornell, J. P. Huyen, I. Gibson, E. Kraus, R. Mannon, M. Naesens, V. Nickeleit, P. Nickerson, D. Segev, H. Singh, M. Stegall, P. Randhawa, L. Racusen, K. Solez, M. Mengel
9 2018
9
🐜
🦁 Immunosuppressive drugs for kidney transplantation.
P. Halloran
9 2004
9
🦁
🐜 Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
32 auth. K. Solez, R. Colvin, L. Racusen, M. Haas, B. Sis, M. Mengel, P. Halloran, W. Baldwin, G. Banfi, A. Collins, F. Cosio, D. David, C. Drachenberg, G. Einecke, A. Fogo, ... I. Gibson, D. Glotz, S. Iskandar, E. Kraus, E. Lerut, R. Mannon, M. Mihatsch, B. Nankivell, V. Nickeleit, J. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, I. Roberts, D. Serón, R. Smith, M. Valente
9 2008
9
🐜
🐜 Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups
33 auth. B. Sis, M. Mengel, M. Haas, R. Colvin, P. Halloran, L. Racusen, K. Solez, W. Baldwin, E. Bracamonte, V. Broecker, F. Cosio, A. Demetris, C. Drachenberg, G. Einecke, J. Gloor, ... D. Glotz, E. Kraus, C. Legendre, H. Liapis, R. Mannon, B. Nankivell, V. Nickeleit, J. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, E. Rodriguez, D. Serón, S. Seshan, M. Suthanthiran, B. Wąsowska, A. Zachary, A. Zeevi
9 2010
9
🐜
🦁 Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
P. Halloran, T. Mathew, S. Tomlanovich, C. Groth, L. Hooftman, C. Barker
9 1997
9
🦁
🐜 Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation
12 auth. F. Vincenti, R. Kirkman, S. Light, G. Bumgardner, M. Pescovitz, P. Halloran, ... J. Neylan, A. Wilkinson, H. Ekberg, R. Gaston, Lars Backman, J. Burdick
9 1998
9
🐜
🐜 Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
13 auth. R. Gaston, J. Cecka, B. Kasiske, A. Fieberg, R. Leduc, F. Cosio, S. Gourishankar, J. Grande, P. Halloran, L. Hunsicker, ... R. Mannon, D. Rush, A. Matas
8 2010
8
🐜